SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹34 Cr | ₹24 Cr | ₹33 Cr | ₹36 Cr | ₹15 Cr |
What is the latest Cash Flow from Operating Activities ratio of SAKAR HEALTHCARE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹15 Cr |
How is Cash Flow from Operating Activities of SAKAR HEALTHCARE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 39.09 | |
| Mar2024 | ₹24 Cr | -26.62 | |
| Mar2023 | ₹33 Cr | -6.60 | |
| Mar2022 | ₹36 Cr | 144.90 | |
| Mar2021 | ₹15 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,035.6 Cr | 14.6% | 8.6% | 158.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 14.6% |
8.6% |
158.3% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses